The Latest Breaking News from CMS

Insurers, Republicans square off with Biden on Medicare ‘cuts’

WASHINGTON — The insurance industry and Republicans are using the debt ceiling fight and President Joe Biden’s vows not to cut Medicare to fend off changes to private Medicare Advantage plans, which are popular among the public but have faced criticism about their costs to the government.

Tribune News Service · Feb 22, 2023

Insurers, Republicans square off with Biden on Medicare 'cuts' - Roll Call

Medicare Advantage, a Medicare alternative primarily run by private health insurers, becomes a battleground in the war over federal spending.

Roll Call · Feb 22, 2023

LOCALIZE IT: Health facilities cited for COVID vaccinations

EDITORS/NEWS DIRECTORS:

The Independent UK · Feb 19, 2023

They openly ripped off Medicare

Health plans will be allowed to pocket hundreds of millions of dollars in overcharges for audits before 2018

Salon · Feb 1, 2023

DWP announces big changes to the way child maintenance is paid

Plans to protect parents from abusive ex-partners come after coroner calls for reform following the tragic death of Emma Day

Chronicle Live · Feb 1, 2023

Medicare Advantage plans overcharged government hundreds of millions but get to hang onto the money

The federal Medicare agency will require next to nothing from insurers for excess payments they got from 2011 to 2017 and won’t impose big penalties until audits for 2018 and beyond are conducted, which could be years.

Chicago Sun-Times · Jan 31, 2023

Commentary: We shouldn’t get caught up in the hype over new Alzheimer’s drug

This month, the Food and Drug Administration approved a new drug, lecanemab, for the treatment of Alzheimer’s disease. The drug, sold under the brand name Leqembi, was developed by Japanese pharmaceutical company Eisai and will be marketed commercially in partnership with American pharmaceutical company Biogen. Biogen, notably, is the maker…

Chicago Tribune · Jan 30, 2023

Did your health plan rip off Medicare?

Previously secret government audits reveal millions of dollars in overpayments to Medicare Advantage health plans

Salon · Jan 29, 2023

Energy transition presents Scotland's 'most significant' challenges and opportunities

Panel of experts at Insider breakfast event states that existing oil and gas industry must be supported in move to renewables

Insider UK · Jan 25, 2023

Commentary: Too soon to celebrate new Alzheimer’s drug

A treatment that improves Alzheimer’s disease would be a great advance, but Leqembi (lecanemab), which recently received accelerated approval from the FDA, is not that drug. Yes, lecanemab slows decline to an extent detectable on a test, but not to an extent that a relative or caretaker would notice. This…

Tribune News Service · Jan 25, 2023